Vistin Pharma ASA : Approval of annual accounts
Post# of 301275
Oslo, Norway, 25 April 2017
The Board of Directors of Vistin Pharma ASA has on 25 April 2017 approved the Directors' report and consolidated financial statements for Vistin Pharma for 2016, in line with the preliminary full year results as presented on 28 February 2017
The annual report for 2016 will be published together with the call for the Annual General Meeting.
For further information, please contact:
Gunnar Manum CFO +47 95 17 91 90
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.